In order to assess whether signaling responses also were altered in tumor-infiltrating T cells in SLL/CLL and MZL, tumor samples were stimulated with IL-2, IL-7 and IL-15 for 15 minutes and phospho-protein levels were evaluated in the CD5+ CD20- T cell fraction (Figure6). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.